Siga Technologies INC Revenues
Siga Technologies INC (SIGA) reported Revenues of $4.26 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-03-05
- Siga Technologies INC revenues for the quarter ending 2019-12-31 was $4.26M, a 171.77% increase year-over-year.
- Siga Technologies INC revenues for the quarter ending 2019-09-30 was $8.11M, a 98.28% decline year-over-year.
- Siga Technologies INC revenues for the quarter ending 2019-06-30 was $3.91M, a 46.86% increase year-over-year.
- Siga Technologies INC revenues for the quarter ending 2019-03-31 was $10.46M, a 498.34% increase year-over-year.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2019-12-31 | $4.26M 10-K · filed 2020-03-05 | $12.38M derived: sum of 2 quarters · filed 2020-03-05 | $16.28M derived: sum of 3 quarters · filed 2020-03-05 | $26.74M derived: sum of 4 quarters · filed 2020-03-05 |
| 2019-09-30 | $8.11M 10-K · filed 2020-03-05 | $12.02M derived: sum of 2 quarters · filed 2020-03-05 | $22.48M derived: sum of 3 quarters · filed 2020-03-05 | $24.05M derived: sum of 4 quarters · filed 2020-03-05 |
| 2019-06-30 | $3.91M 10-K · filed 2020-03-05 | $14.37M derived: sum of 2 quarters · filed 2020-03-05 | $15.94M derived: sum of 3 quarters · filed 2020-03-05 | $487.01M derived: sum of 4 quarters · filed 2020-03-05 |
| 2019-03-31 | $10.46M 10-K · filed 2020-03-05 | $12.03M derived: sum of 2 quarters · filed 2020-03-05 | $483.10M derived: sum of 3 quarters · filed 2020-03-05 | $485.76M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-12-31 | $1.57M 10-K · filed 2020-03-05 | $472.64M derived: sum of 2 quarters · filed 2020-03-05 | $475.31M derived: sum of 3 quarters · filed 2020-03-05 | $477.05M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-09-30 | $471.07M 10-K · filed 2020-03-05 | $473.74M derived: sum of 2 quarters · filed 2020-03-05 | $475.48M derived: sum of 3 quarters · filed 2020-03-05 | $476.90M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $2.66M 10-K · filed 2020-03-05 | $4.41M derived: sum of 2 quarters · filed 2020-03-05 | $5.82M derived: sum of 3 quarters · filed 2020-03-05 | $7.21M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $1.75M 10-K · filed 2020-03-05 | $3.16M derived: sum of 2 quarters · filed 2020-03-05 | $4.55M derived: sum of 3 quarters · filed 2020-03-05 | $8.81M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $1.41M 10-K · filed 2019-03-06 | $2.80M derived: sum of 2 quarters · filed 2019-03-06 | $7.07M derived: sum of 3 quarters · filed 2019-03-06 | $12.27M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-09-30 | $1.39M 10-K · filed 2019-03-06 | $5.66M derived: sum of 2 quarters · filed 2019-03-06 | $10.86M derived: sum of 3 quarters · filed 2019-03-06 | |
| 2017-06-30 | $4.26M 10-K · filed 2019-03-06 | $9.47M derived: sum of 2 quarters · filed 2019-03-06 | ||
| 2017-03-31 | $5.20M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |